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Association of Hyperchloremia With Hospital
Mortality in Critically Ill Septic Patients
Javier A. Neyra, MD1; Fabrizio Canepa-Escaro, MD2; Xilong Li, PhD, MS3; John Manllo, MD4;
Beverley Adams-Huet, MS3; Jerry Yee, MD5; Lenar Yessayan, MD, MS5,6; for the Acute Kidney Injury in
Critical Illness Study Group
Objectives: Hyperchloremia is frequently observed in critically ill
patients in the ICU. Our study aimed to examine the association of
serum chloride (Cl) levels with hospital mortality in septic ICU patients.
Design: Retrospective cohort study.
Setting: Urban academic medical center ICU.
Patients: ICU adult patients with severe sepsis or septic shock
who had Cl measured on ICU admission were included. Those with
baseline estimated glomerular filtration rate less than
15 mL/min/1.73 m2 or chronic dialysis were excluded.
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Interventions: None.
Measurements and Main Results: Of 1,940 patients included
in the study, 615 patients (31.7%) had hyperchloremia (Cl ≥ 110
mEq/L) on ICU admission. All-cause hospital mortality was the
dependent variable. Cl on ICU admission (Cl0), Cl at 72 hours (Cl72),
and delta Cl (ΔCl = Cl72 – Cl0) were the independent variables. Those
with Cl0 greater than or equal to 110 mEq/L were older and had
higher cumulative fluid balance, base deficit, and Sequential Organ
Failure Assessment scores. Multivariate analysis showed that higher
Cl72 but not Cl0 was independently associated with hospital mortality
in the subgroup of patients with hyperchloremia on ICU admission
(adjusted odds ratio for Cl72 per 5 mEq/L increase = 1.27; 95% CI,
1.02–1.59; p = 0.03). For those who were hyperchloremic on ICU
admission, every within-subject 5 mEq/L increment in Cl72 was independently associated with hospital mortality (adjusted odds ratio for
ΔCl 5 mEq/L = 1.37; 95% CI, 1.11–1.69; p = 0.003).
Conclusions: In critically ill septic patients manifesting hyperchloremia (Cl ≥ 110 mEq/L) on ICU admission, higher Cl levels and
within-subject worsening hyperchloremia at 72 hours of ICU stay
were associated with all-cause hospital mortality. These associations were independent of base deficit, cumulative fluid balance, acute kidney injury, and other critical illness parameters.
(Crit Care Med 2015; 43:1938–1944)
Key Words: chloride; hospital mortality; hyperchloremia; ICUs;
sepsis

C

hloride is the most abundant anion in the extracellular
fluid and constitutes approximately one third of the
extracellular fluid tonicity (1). Chloride plays a pivotal
role in many body functions including acid-base balance, muscular activity, osmosis, and immunomodulation (2). Despite its
physiologic importance, chloride has captured little attention
by the scientific community until recently (3) when chloriderich solutions were associated with hyperchloremic metabolic
acidosis (4, 5) and short-term mortality after noncardiac
surgery (6, 7). The precise mechanisms of hyperchloremic
metabolic acidosis are somewhat controversial: 1) Hco3– dilution (8), 2) chloride as a key contributor to the decrease in
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strong ion difference influencing the dissociation of water with
H+ generation (Stewart approach) (9), and 3) the unbalanced
dilution of the buffer system (Hco3– but not CO2) (10).
The most common chloride-rich solution used in clinical practice is 0.9% saline (11), particularly in critical illness
and perioperatively, and 0.9% saline is in reality a non-neutral
solution (12) and has a supraphysiologic amount of chloride
when compared with plasma (154 vs ~100 mEq/L, respectively) (13, 14). The consequent hyperchloremic metabolic acidosis derived from the liberal use of chloride-rich solutions has
been described as a common but poorly recognized disorder
in critically ill patients (15, 16), with numerous detrimental
consequences (17, 18), particularly in those with severe sepsis
and septic shock (19).
Critically ill septic patients are commonly exposed to 0.9%
saline during the salvage phase of shock and therefore are
susceptible to hyperchloremia in the postresuscitation phase.
However, observational studies evaluating the association of
hyperchloremia with hospital mortality have shown conflicting results and included only a small number of septic patients
in the ICU (20–22).
The purpose of our study was to determine whether there
was an independent association of serum chloride (Cl) levels
at two different time points of ICU stay with hospital mortality
in critically ill septic patients. The two evaluated Cl time points
were ICU admission (Cl0) and 72 hours of ICU stay (Cl72). We
hypothesized that higher Cl72 would be independently associated with hospital mortality, particularly in those patients who
were hyperchloremic at the time of ICU admission.

MATERIALS AND METHODS
Study Design and Participants
We conducted a single-center observational retrospective cohort
study using a population-based ICU database of patients with
severe sepsis or septic shock admitted to an urban tertiary care
hospital from May 2007 through April 2012. Severe sepsis or
septic shock was defined by Angus criteria (23), using the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes (24) for a bacterial or fungal infection
and a diagnosis of acute organ dysfunction excluding gastrointestinal failure. We included all adult patients admitted to the ICU
with a diagnosis of severe sepsis or septic shock who had at least
one serum creatinine (SCr) measurement that was documented
in the medical records within 3 months prior to ICU admission
and one Cl measured at Cl0. We excluded patients with baseline
estimated glomerular filtration rate (eGFR) less than 15 mL/
min/1.73 m2 using the four-variable Modification of Diet in
Renal Disease study equation (25), those undergoing any form
of chronic dialysis, and those with absent recorded daily fluid
balance within the first 72 hours of ICU stay. The protocol was
approved by the hospital’s institutional review board (#7044).
Study Variables
Serum chloride was measured by indirect potentiometry
(SYNCHRON Systems; Beckman Coulter, Brea, CA). The
Critical Care Medicine

delta chloride (ΔCl) was defined as the difference between Cl72
and Cl0. The Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment
(SOFA) scores were calculated after integration of clinical and
laboratory data within the first day of ICU admission. Cumulative fluid balance (CFB) was calculated based on total fluid
input minus output within the first 72 hours of ICU stay. These
data did not include pre-ICU fluid administration. Base deficit
was calculated by subtracting the serum Hco3– measurement
on ICU admission from the normal serum Hco3– value of 24
mEq/L. Subject-specific variables were obtained from electronic medical records (EMRs). Acute kidney injury (AKI)
was adjudicated based on Kidney Disease Improving Global
Outcomes consensus SCr-based criteria by comparing the
highest SCr measured within the first 72 hours of admission
and the reference SCr within 3 months before admission (26).
Comorbidities (e.g., diabetes, hypertension, and heart failure)
were identified using ICD-9-CM codes, except for anemia that
was defined as admission hematocrit less than 39% for men
and less than 36% for women. Data pertaining to drug exposure, red blood cell transfusion, and mechanical ventilation
were based on hospital billing codes for the indexed admission within the time frame of the study. All collected data were
validated through comprehensive individual review of 10% of
EMRs by data management personnel blinded to the study.
Study Outcomes
The observation period lasted from ICU admission until the
time of hospital discharge or death. The primary outcome
measure was all-cause hospital mortality and was adjudicated
based on EMR review by data management personnel blinded
to the study.
Statistical Analysis
The study sample was analyzed as a single group and divided in
two subgroups based on Cl levels at the time of ICU admission:
hyperchloremia (Cl0 ≥ 110 mEq/L) and no hyperchloremia
(Cl0 < 110 mEq/L). Categorical data were reported as percentages and continuous data as means ± sd or median (interquartile range). The comparisons between groups for categorical
variables were made using the chi-square test. For normally distributed continuous variables, a two-sided t test was used. The
Wilcoxon signed rank test was used for nonparametric data.
The associations between hospital mortality (dependent
variable) and 1) Cl at the time of ICU admission (Cl0), 2) Cl
at 72 hours of ICU stay (Cl72), 3) ΔCl (ΔCl = Cl72 – Cl0), and
4) their interaction with hyperchloremia at the time of ICU
admission (Cl0 ≥ 110 mEq/L) were examined using logistic
regression analysis. The associations between hospital mortality and the independent variables of interest (Cl0, Cl72, and ΔCl)
were further examined in all patients and separately in both
subgroups (hyperchloremia vs no hyperchloremia at the time
of ICU admission) in multivariate logistic regression models
that adjusted for confounders known to be associated with
hospital mortality. The multivariate logistic regression model
adjusted for candidate variables that had a p value less than
www.ccmjournal.org
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0.10 in the univariate models. Candidate variables included
demographic data (age, gender, and race), comorbidity (baseline eGFR, diabetes, hypertension, heart failure, and anemia),
indicators of critical illness (AKI, oliguria, APACHE II, SOFA,
CFB, base deficit, mechanical ventilation, blood transfusion,
and length of ICU stay), and drug exposure (diuretic, statin,
aminoglycoside, and IV or intra-arterial iodine contrast).
Only one of the two variables was included in the event of
collinearity between variables. Covariate adjustment was also
assessed with propensity score analysis (sensitivity analysis)
using quintiles of the propensity scores in the logistic regression model for hospital mortality. The 95% CIs reported for
the logistic regression odds ratios (ORs) were calculated by
the Wald estimation. Two-sided p values less than 0.05 indicated statistical significance. Spreadsheet software and SAS
9.3 (SAS Institute, Cary, NC) were used in data acquisition
and analysis.

RESULTS
Of 6,490 patients examined for eligibility, 1,940 satisfied inclusion and exclusion criteria (Fig. 1). Of these, 615 patients
(31.7%) had hyperchloremia (Cl0 ≥ 110 mEq/L) on ICU admission. The median Cl0 was 113 mEq/L (111–116 mEq/L) in the
hyperchloremic subgroup and 104 mEq/L (100–107 mEq/L)
in the nonhyperchloremic subgroup. During the observation period, from ICU admission until hospital discharge or
death, 431 patients (22.2%) died: 147 (23.9%) in the subgroup
with and 284 (21.4%) in the subgroup without hyperchloremia at admission. Baseline demographics and clinical characteristics of these two subgroups are provided in Table 1. The
patients with hyperchloremia on ICU admission were older;
more frequently African-Americans; and had higher CFB, base
deficit, and APACHE II and SOFA scores. Furthermore, these
patients required more blood transfusions, vasoactive drugs,
and mechanical ventilation and were more frequently oliguric

when compared with those without hyperchloremia at the
time of ICU admission (Cl0 < 110 mEq/L) (Table 1). Cl72 was
available in 353 patients with and 726 without hyperchloremia
at the time of ICU admission.
Cl0 was not associated with all-cause hospital mortality (ORCl0 per 5 mEq/L increase = 1.04; 95% CI, 0.97–1.12;
p = 0.25). Furthermore, no difference was found in the effect
of Cl0 on hospital mortality when stratified by the presence
or absence of hyperchloremia (Cl0 ≥ 110 vs < 110 mEq/L)
(Table 2).
Cl72 was associated with increased odds for hospital mortality in all patients. Each 5 mEq/L increase in Cl72 was associated
with a 12% increase in odds for hospital mortality (ORCl72 per 5
mEq/L increase = 1.12; 95% CI, 1.01–1.24; p = 0.03) (Table 2).
There was statistical interaction between Cl72 and the presence
or absence of hyperchloremia on ICU admission (p = 0.02).
The increased odds for hospital mortality was detected only
in those with hyperchloremia on ICU admission (Cl0 ≥ 110
mEq/L) (ORCl72 per 5 mEq/L increase = 1.38; 95% CI, 1.13–
1.68; p = 0.002) but not in those with Cl0 less than 110 mEq/L
on presentation (ORCl72 per 5 mEq/L increase = 1.05; 95% CI,
0.92–1.20; p = 0.46) (Table 2).
In a multivariate model of the subgroup of patients with
hyperchloremia at the time of ICU admission (Cl0 ≥ 110
mEq/L), Cl72 retained its significant association with hospital
mortality (adjusted ORCl72 per 5 mEq/L increase = 1.27; 95%
CI, 1.02–1.59; p = 0.03) (Table 3).
Within-subject increase in Cl from ICU admission to
72 hours (ΔCl = Cl72 – Cl0) was also associated with hospital mortality. Among all study subjects, each within-subject 5
mEq/L increase in Cl was associated with a 15% increase in
the odds for hospital mortality (OR = 1.15; 95% CI, 1.05–1.29;
p = 0.003) (Table 2). However, the increase in hospital mortality was solely driven by subjects with hyperchloremia on ICU
admission. The odds for hospital mortality increased by 35%
for each within-subject 5 mEq/L increment (ΔCl = 5 mEq/L)
in those with hyperchloremia on ICU admission (Table 2). This
association persisted in a multivariate model that adjusted for
confounders (adjusted OR for ΔCl 5 mEq/L = 1.37; 95% CI,
1.11–1.69; p = 0.003) (Table 3).
As part of a sensitivity analysis, the propensity score–
adjusted estimates for Cl72 and ΔCl 5 mEq/L yielded results
similar to the multivariate models in Table 3 (among hyperchloremic patients at the time of ICU admission): adjusted
ORCl72 per 5 mEq/L increase = 1.29; 95% CI, 1.04–1.59;
p = 0.02 and adjusted OR for ΔCl 5 mEq/L = 2.84; 95% CI,
1.32–6.13; p = 0.008.

DISCUSSION

Figure 1. Cohort derivation and study scheme. CFB = cumulative fluid
balance, Cl0 = serum chloride at the time of ICU admission, eGFR =
estimated glomerular filtration rate, SCr = serum creatinine.
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In our study, we found an independent association between
higher Cl72 and all-cause hospital mortality in critically ill septic patients who were hyperchloremic (Cl0 ≥ 110 mEq/L) at the
time of ICU admission. Interestingly, the association of hyperchloremia and hospital mortality persisted after adjustment
for several confounders including CFB (effect of fluid therapy,
particularly 0.9% saline), base deficit (effect of metabolic
September 2015 • Volume 43 • Number 9
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Table 1. Clinical Characteristics Stratified by Serum Chloride at the Time of ICU
Admission
Variable

Cl0 ≥ 110 mEq/L (n = 615)

p

Cl0 < 110 mEq/L (n = 1,325)

Demographics
67.8 ± 15.9

65.1 ± 15.8

< 0.001a

 Male, %

48.3

54.2

0.02a

 African-American, %

47.6

35.3

< 0.001a

 Age, yr, mean ± sd

Chronic conditions
 Baseline serum creatinine,
mg/dL, median (IQR)
 Baseline eGFR, mL/min/1.73 m2,
median (IQR)

1.2 (0.9–1.6)

1.2 (0.9–1.6)

0.07

61.9 (42.7–82.8)

62.9 (44.8–88.2)

0.09

 Diabetes, %

21.5

21.9

0.83

 Hypertension, %

43.6

42.9

0.79

 Heart failure, %

2.9

3.0

0.91

90.3

83.8

< 0.001a

 Diuretic, %

37.2

42.4

0.045a

 Statin, %

26.2

30.3

0.07

 Iodine contrast, %

23.1

29.1

0.005a

 Aminoglycoside, %

8.0

5.3

0.02a

 Anemia, %
Drug exposure at 72 hr

Critical indicators on ICU admission
6.1 ± 6.2

2.0 ± 7.3

< 0.001a

 Acute Physiology and Chronic Health
Evaluation II score, mean ± sd

16.5 ± 7.3

13.2 ± 6.1

< 0.001a

 Sequential Organ Failure Assessment
score, mean ± sd

6.6 ± 4.0

5.3 ± 3.8

< 0.001a

15.0

10.0

5.4 ± 7.0

3.3 ± 6.4

Vasopressor or inotrope, %

41.6

32.8

0.001a

Mechanical ventilation, %

49.4

38.9

< 0.001a

5.0

2.3

0.002a

61.1

57.0

 Base deficit, mEq/L, mean ± sd

Critical indicators at 72 hr
 Oliguria, %
 Cumulative fluid balance 72 hr, L,
mean ± sd

Red blood cell transfusion, %
AKI, %
Length of hospital stay, d, median (IQR)

11.0 (6–20)

0.003a
< 0.001a

12.0 (7–20)

0.09
0.51

Cl0 = serum chloride at the time of ICU admission, IQR = interquartile range, eGFR = estimated glomerular filtration rate based on Modification of Diet in Renal
Disease study equation (20); iodine contrast only if IV or intra-arterial; oliguria defined as urine output < 500 mL in 24 hr, AKI = acute kidney injury based on
Kidney Disease Improving Global Outcomes consensus serum creatinine–based criteria.
a
Statistically significant, p < 0.05.

acidosis), AKI (effect of renal handling of chloride), and SOFA
score (effect of severity of critical illness). Most importantly,
every 5 mEq/L within-subject increment in Cl72 was independently associated with a 37% increase in the odds for hospital
mortality in those patients who were already hyperchloremic
on ICU admission.
Critical Care Medicine

Our study adds to the growing body of evidence showing
that elevated Cl levels may be harmful in certain inpatient populations. Three observational studies have evaluated the association of hyperchloremia with hospital mortality in critically
ill patients with systemic inflammatory response syndrome
(SIRS) (20–22). These studies showed conflicting results and
www.ccmjournal.org
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Table 2. Univariate Association of Hospital Mortality With 1) Serum Chloride at the Time
of ICU Admission, 2) Serum Chloride at 72 Hours of ICU Stay, and 3) Within-Subject
Time-Related Change in Serum Chloride From ICU Admission to 72 Hours (ΔCl) in All
Patients and Stratified by the Presence of Hyperchloremia at the Time of ICU Admission
No Hyperchloremia
on Admission
(Cl0 < 110)

All Patients
Odds Ratio

p

Cl0 (per 5 mEq/L)

1.04 (0.97–1.12)

Cl72 (per 5 mEq/L)
ΔCl (per 5 mEq/L)

Variable

Hyperchloremia
on Admission
(Cl0 ≥ 110)

Odds Ratio

p

0.25

0.95 (0.84–1.08)

0.43

1.18 (0.99–1.40)

0.07

1.12 (1.01–1.24)

0.03

1.05 (0.92–1.20)

0.46

1.38 (1.13–1.68)

0.002a

1.15 (1.05–1.29)

0.003a

1.13 (0.99–1.28)

0.07

1.35 (1.11–1.64)

0.003a

a

p

Odds Ratio

Cl0 = serum chloride at the time of ICU admission, Cl72 = serum chloride at 72 hr of ICU stay, ΔCl = Cl72 – Cl0.
a
Statistically significant, p < 0.05.

included only a small number of patients with severe sepsis
or septic shock. One study in 488 critically ill patients did not
show an association between Cl and mortality (21). Notably,
the hospital mortality rate in this study was only 3%, precluding the ability to establish a firm conclusion. The other two
studies revealed an association between Cl and hospital mortality. The first study was a prospective cohort of 175 critically ill
patients in the ICU, 48% of whom had sepsis (20). The second
study was a large retrospective cohort study of patients with
SIRS, with only 6.8% reported to have sepsis (22). Both studies
tested the univariate association between Cl levels and hospital
mortality and neither adjusted for any potential confounders.
Critically ill septic patients are frequently exposed to
chloride-rich solutions during resuscitation. The potential
adverse effects of excessive chloride-rich crystalloid infusions
have been suggested in two large retrospective cohort studies.
Raghunathan et al (27) found a reduction in hospital mortality associated with the use of balanced IV fluids, and Shaw et al
(22) demonstrated an association between higher IV chloride
loads and hospital mortality.

The excessive administration of chloride-rich solutions may
have detrimental consequences in the kidney. Small experimental studies in animals and humans have shown reductions
in renal blood flow, glomerular filtration rate, and renal cortical tissue perfusion when exposed to high IV chloride loads
(28, 29). A large prospective study, using a quasiexperimental
design, reported a lower incidence of AKI when a chloriderestrictive fluid strategy was implemented in the ICU (30).
Interestingly, we found that patients with hyperchloremia on
ICU admission were more commonly oliguric when compared
with those without hyperchloremia (Table 1).
Furthermore, evidence has shown that chloride-rich solutions may alter coagulation parameters and predispose to
bleeding after major surgery (31, 32). In our cohort, we found
that patients who were hyperchloremic on ICU admission had
more commonly anemia and required more blood transfusions when compared with their nonhyperchloremic counterparts (Table 1).
The pathophysiologic mechanisms underlying the association between hyperchloremia and hospital mortality in sepsis

Table 3. Multivariate Analysis of Hospital Mortality as the Dependent Variable Among
Hyperchloremic Patients at the Time of ICU Admission (Cl0 ≥ 110 mEq/L) for 1) Serum Chloride
at the Time of ICU Admission, 2) Serum Chloride at 72 Hours of ICU Stay, and 3) Within-Subject
Time-Related Change in Serum Chloride From ICU Admission to 72 Hours (ΔCl)
Multivariate Model for Cl0
Odds Ratio Hospital
Mortality

p

Odds Ratio Hospital
Mortality

p

Cl0 (per 5 mEq/L)

0.84 (0.65–1.07)

0.16

—

—

Cl72 (per 5 mEq/L)

—

—

1.27 (1.02–1.59)

ΔCl (per 5 mEq/L)

—

—

—

Variable

Multivariate Model for ΔCl

Multivariate Model for Cl72

Odds Ratio Hospital
Mortality

p

—

—

0.03

—

—

—

1.37 (1.11–1.69)

0.003a

a

Cl0 = serum chloride at the time of ICU admission, Cl72 = serum chloride at 72 hr of ICU stay, ΔCl = Cl72 – Cl0.
a
Statistically significant, p < 0.05.
Multivariate models adjusted for age, gender, hypertension, acute kidney injury (Kidney Disease Improving Global Outcomes serum creatinine–based criteria),
oliguria, cumulative fluid balance, vasopressor or inotrope requirements, mechanical ventilation, Sequential Organ Failure Assessment (SOFA) score, and base
deficit. Multivariate models included all variables associated with hospital mortality on univariate analysis at p < 0.10. Acute Physiology and Chronic Health
Evaluation II was not included in the multivariate model because of collinearity with the SOFA score.
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remain to be determined. Host immunity is a key component
in the manifestation of critical illness including sepsis. In vitro
cell models have demonstrated an augmented proinflammatory response to hyperchloremic metabolic acidosis mediated
by nitric oxide and higher interleukin (IL)-6 to IL-10 ratio
when compared with lactic acidosis (33). These observations
were reproduced in murine septic models whereby hyperchloremic metabolic acidosis increased circulating levels of IL-6,
IL-10, and tumor necrosis factor (34). Similarly, increased
nitric oxide production was observed in hydrochloric acid–
induced experimental acidosis (35, 36). Therefore, hyperchloremic metabolic acidosis may be a proinflammatory modulator
in sepsis.
Chloride also plays an important role in neutrophil function. Neutrophil phagosomes require a continuous influx of
chloride through different chloride channels and cotransporters (37, 38) in order to provide substrate for hypochloric acid generation by myeloperoxidase (39). Low or absent
extracellular chloride concentration has been associated
with decreased neutrophil function (40, 41). It is not known
whether high extracellular chloride generates an augmented
neutrophil response, which could further contribute to the
proinflammatory imbalance observed in sepsis and hyperchloremic acidosis.
Our results should be interpreted with caution. The observational nature of our investigation is susceptible to bias and
confounding. Selection bias may be possible given the rigorous inclusion and exclusion criteria. However, selection bias
due to missing values is unlikely because data were not missing in a systematic differential manner between the two subgroups. Similar to any other observational study, information
on comorbidities is dependent on EMR documentation, which
may increase the risk of information bias. However, there is no
reason to believe that there would be a systematic differential
information bias between the two subgroups. Furthermore,
data were electronically extracted from EMRs by data management personnel blinded to the study. The accuracy of data
collection was further validated by individual EMR review of
10% of data. Although we adjusted for confounding by rigorous multivariate regression analyses including covariate
adjustment using propensity scores, residual confounding by
unmeasured covariates may not have been completely eliminated. Finally, given the observation period and objectives of
our study, data pertaining to the amount of fluid administered
before ICU admission or the type of fluid (chloride load) were
not available.
The strengths of our study are its large sample size, the careful selection of a representative sample of patients with severe
sepsis or septic shock admitted to the ICU, and the multivariate adjustment for clinical confounders directly linked to
hyperchloremia and hospital mortality such as base deficit,
CFB, AKI, and comprehensive critical illness severity scores.
None of the studies that have previously revealed the association between Cl levels and hospital mortality accounted for
confounding. Our study is unique in the multivariate design
and patient population.
Critical Care Medicine

CONCLUSIONS
Critically ill septic patients with hyperchloremia at the time
of ICU admission represent an overall sicker population. In
patients manifesting hyperchloremia (Cl ≥ 110 mEq/L) on
ICU admission, higher Cl levels and worsening within-subject
hyperchloremia at 72 hours of ICU stay were independently
associated with all-cause hospital mortality. The avoidance of
chloride-rich solutions in this specific subgroup of patients
may have a greater impact on mortality outcomes. Although
the effect of hyperchloremia on mortality appears independent
of metabolic acidosis, a potential causal relationship between
hyperchloremia and mortality requires further exploration.
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